1
1
1 Sohag University - - PowerPoint PPT Presentation
1 1 Sohag University Faculty of Science " Physicochemical and Biological Studies: Embryos
1
1
2
Sohag University Faculty of Science
3
Faculty of Science, Sohag University
Assistant Prof. of Inorganic Chemistry, Faculty of Science, Sohag University
Assistant Prof. of physical chemistry, Faculty of Science, Sohag University
4
5
6
[1] Sandermann, W., Naturharze Terpentinol-TalloChemie und Technologie, Berlin: Springer, 1960,303-310
[2]Gehad G. MOHAMED, Mohamed M. OMAR, Ahmed M. HINDY, Turk J Chem,30 (2006) , 361
– 38
7
transition metal ions is utilized in preparing their solid complexes
complexes play an essential role in agriculture, pharmaceutical and industrial chemistry.
they have industrial, antifungal [3], antibacterial [4], anticancer [5] and herbicidal applications[6]
[3]- Daniel, V. P.; Murukan, B.; Kumari, B. S.; Mohanan, K. Spectrochim Acta Part A 2008, 70, 403. [4]-Prashanthi, Y.; Kiranmai, K.; Subhashini, N. J. P.; Shivaraj, S. Spectrochim Acta Part A 2008, 70, 30. [5]- Galal, S. A.; Hegab, K. H.; Kassab, A. S.; Rodriguez, M. L.; Kerwin, S. M.; El-Khamry, A.-M. A.; El Diwani, H. I. Eur J Med Chem 2009, 44(4), 1500. [6]-Cozzi, P.G., Chem. Soc. Rev. 2004, 33, 410-42
8
Monamine oxidase enzyme B
[7]Du Preez, J. G. H.; Gerber, T. I. A.; Fourie, P. J.; Van Wyk, A. J., J. Coord. Chem., 1984, 13, 173
9
[8]Sheldon, R. A.; Kochi, J. K., Metal Catalyzed Oxidations of Organic Compounds; Academic Press: New York, 1981 [9] Dede, B.; Karipcin, F.; Cengiz, M. J. HazardMater 2009, 163(2–3), 1148. [10] K.C. Gupta, A.K. Sutar, J. Mol. Catal. A: Chem. 272 (2007) 64.
[11]Bagherzadeh, M.; Tahsini, L.; Latifi, R.; Amani, V.; Ellern, A.; Woo, L. K., Inorg. Chem. Commun., 2009, 12,
476 [12] Abbo, H. S.; Titinchi, S. J. J.; Prasad, R.; Chand, S., J. Mol. Catal. A: Chem., 2005, 225, 225
10
[13]Bagherzadeh, M.; Tahsini, L.; Latifi, R.; Amani, V.; Ellern, A.; Woo, L. K., Inorg.
11
[14] El-Said, A. I.; Zidan, A. S. A.; El-Meligy, M. S.; Aly, A. A. M.; Mohammed, O. F. Transition Met Chem 2001, 26, 13. [15] Wang, Z.-M.; Lin, H.-K.; Zhu, S.-R.; Liu, T.-F.; Chen, Y.-T. J Inorg Biochem 2002, 89, 97. [16] Wang, M.-Z.; Meng, Z.-X.; Liu, B.-L.; Cai, G.-L.;Zhang, C.-L.; Wang, X.-Y. Inorg Chem Commun 2005, 8(4), 368.
12
salicylaldehyde derivatives have gained remarkable attention because they are intermediates in many metabolic reactions[17]
[17]- Nath, M.; Yadov, R. Bull Chem Soc Jpn 1997, 70, 131.[9 [18]Wang, M.-Z.; Meng, Z.-X.; Liu, B.-L.; Cai, G.-L.; Zhang, C.-L.; Wang, X.-Y., Inorg.
biosynthesis of hormones, neurotransmitters, and pigments.
constitute new kinds of potential antibacterial and anticancer reagents[18]
13
[19] Nasser M. Hosny and Farid I. El-Dossoki, J. Chem. Eng. Data 2008, 53, 2567–2572
14
[41]Morrow, J.R., Inorg. Chem., 2000, 39, 2130. [42]Liu, C.; Wang, M.; Zhang, T.; Sun, H., Coord. Chem. Rev., 2004, 248, 147 [43]Wang, X.Y.; Zhang, J.; Li, K.; Jiang, N.; Chen, S.Y.; Lin, H.H.; Huang, Y.; Ma, L.J.; Yu, X.Q.,
[44]Raman, N.; Fathima, S. S. A.; Raja, J. D., J. Serb. Chem. Soc., 2008, 73(11) [45]Mahalakshmi, N; Rajavel, R., Inter. J. Pharm. Techn., 2010, 2(4), 1133 [46]Zhang, Y.; Wang, X.; Ding, L., Nucleos. Nucleot. Nucl., 2011, 30, 49 [47]Erkkila, K. E.; Odom, D.T.; Barton, J. K., Chem. Rev., 1999, 99, 2777
15
16
17
O OH N H2 O OH R N O OH R OH
+
HN AA H2L
N O OH R OH
H2L 2
Fe
2+
+
COO R H N O H N O H OOC Fe R H
Fe(HL)2
+ 2H+
18
where HN = 2-hydroxy-1-naphthaldehyde, AA = amino acid, H2L = Schiff base amino acid ligand, Fe(H2L)2 = nali, nphali, nasi, nari complexes and FeL = nhi complex.
N
HO
O N
H N
+ 2H+
FeHL
3
L + Fe2+ H
OH
N
O
O N
H N O
Fe
H2O
O H2
19
Analysis Found (Calculated) Decom. temp. (oC) Molar conductance Λm (Ω-1 cm2 mol-1) Yield (%) Empirical Formula (Formula Weight) Comp. N H C 5.61 (5.76) 5.17 (5.39) 69.25 (69.12) 162 83 C14H13NO3 (243.254) nal 4.88 (4.86) 4.67 (4.90) 58.50 (58.34) 260 35.12 75 C28H28FeN2O8 (576.37) nali 4.45 (4.39) 5.21 (5.37) 75.35 (75.22) 170 85 C20H17NO3 (319.346) nphal 3.76 (3.94) 4.57 (4.82) 67.85 (67.61) >350 28.24 83 C40H34FeN2O7 (710.54) nphali 4.72 (4.88) 4.63 (4.56) 62.81 (62.73) 97 73 C15H13NO5 (287.168) nas 4.21 (4.33) 3.92 (4.05) 56.01 (55.74) 185 39.31 72 C30H26FeN2O11 (646.38) nasi 13.44 (13.59) 4.72 (4.89) 66.13 (66.01) 156 85 C17H15N3O3 (309.32) nh 9.58 (9.66) 4.72 (4.86) 46.83 (46.91) >350 47.61 81 C17H21FeN3O7 (435.22) nhi 17.21 (17.07) 6.05 (6.14) 62.29 (62.18) 133 86 C17H20N4O3 (328.37) nar 14.43 (14.66) 5.72 (5.80) 53.64 (53.40) 235 32.21 84 C34H44FeN8O9 (764.62) nari
Analytical and physical data of Schiff base amino acid ligands and their Fe(II) complexes.
20
υ (Fe-O) υ (Fe-N) υ (C-O) phen υ COO-) asym υ (COO-) υ (-C=N) υ(OH); H2O Schiff base ligands and their complexe s _____ _____ 1362 (m) 1528 (w) 1413 (m) 1630 (s) 3403 (w) nal 490 (m) 552 (w) 1314 (m) 1548 (w) 1395 (m) 1622 (s) 3439 (m) nali _____ _____ 1326 (m) 1597 (m) 1405 (w) 1624 (s) 3466 (w) nphal 497 (m) 559 (w) 1315 (w) 1542 (w) 1394 (w) 1614 (s) 3440 (m) nphali _____ _____ 1319(m) 1590 (w) 1462(m) 1640 (s) 3440 (m) nas 482 (m) 550 (w) 1311(m) 1550 (w) 1404(w) 1629 (s) 3430 (m) nasi _____ _____ 1352 (m) 1531 (w) 1370 (m) 1626 (s) 3421 (m) nh 491(m) 563 (m) 1294 (w) 1537 (w) 1360 (m) 1610 (s) 3405 (w) nhi _____ _____ 1341 (w) 1577 (w) 1377 (m) 1639 (s) 3413 (w) nar 465(w) 553 (w) 1296 (m) 1537 (w) 1361 (w) 1630 (s) 3421(w) nari
The infrared absorption frequencies (cm-1)a of the investigated Schiff base amino acid ligands and their Fe(II)complexes.
21 Molecular electronic spectra of (1) [nali] = 5x10-4 mol dm-3, (2) [nphali] = 2.5x10-4 mol dm-3, (3) [nasi] = 5.4x10-4 mol dm-3, (4) [nhi] = 5x10-4 mol dm-3, (5) [nari]=6x10-4 mol dm-3.
22 The stoichiometry and the stability constants of the prepared complexes have been determined spectrophotometrically Continuous variation plots for the prepared complexes in aqueous-alcoholic mixture at [nali] = 3 × 10-3 M , [nphali] = 3 × 10-3 M, [nasi] =5× 10-3 M, [nhi] = 2× 10-3 M, [nari] = 1×10-3 M and 298 K.
23 Molar ratio plots for the studied complexes in aqueous- alcoholic mixture at nali, nphali: [Fe2+] = 6 × 10-4 M; nasi: [Fe2+] = 1 × 10-3 M; nhi: [Fe2+] = 4 × 10-4 M; nari: [Fe2+] = 1 × 10-3 M and 298 K.
24 The formation constant (Kf), stability constant (pK) and Gibbs free energy (ΔG) values of the prepared complexes in aqueous-ethanol at 298 K
25
Dissociation curve of the prepared complexes in aqueous alcoholic mixture at [complex] = 5 × 10-3 M and 298 K.
26
Photographs of chick embryos exposed to 100 µg/ egg of the investigated complexes.
27
28 Mean weight of chick embryos exposed to 100 µg/ egg of the investigated complexes.
29 (a) Spectrophotometer titration of nali complex (10-3 M) in 0.01 M Tris buffer (pH 7.5, 25 °C) with CT-DNA (from top to bottom, 0-50 µM DNA, at 10 µM intervals). (b) Plot of [DNA]/(εa - εf) versus [DNA] for the titration
300 400 500 600 700 0.0 0.5 1.0 1.5 2.0 2.5 3.0
1 2 3 4 5 6 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0
10
8[DNA]/
(a-f) 10
5[DNA]
(b) (a)
nali+ DNA nali
Abs.
(nm)
30
ΔG0 kJ mol-1 Binding Constant Kb×104 M-1 Type of chromism Chromism (%)a Δn (nm) λmax bound (nm) λmax free (nm) Complex
3.72 Hypo Hypo 10.30 16.06 4 26 512 372 516 346 nali
2.94 Hypo Hypo 9.11 16.19 6 34 516 384 522 350 nphali
3.51 Hypo Hyper 19.85 10.15 2 10 518 392 520 382 nasi
35.73 Hypo Hypo 9.25 14.53 4 21 514 384 518 363 nhi
6.02 Hypo Hypo 4.06 27.16 4 36 498 390 502 354 nari
Spectral parameters for DNA interaction with the prepared complexes
f b b f b f a
31 The effect of increasing the amount of the synthesized complexes on the relative viscosities of DNA at [DNA] = 0.5 mM, [complex] = 25-250 µM and 298 K.
0.0 0.1 0.2 0.3 0.4 0.5 1.0 1.1 1.2 1.3 1.4 1.5 1.6
[Complex]/ [DNA]
1/3
nhi nari nali nasi nphali EB
32
Laila H. Abdel-Rahman, Rafat M. El-Khatib, Lobna A. E. Nassr and Ahmed M. Abu-Dief, J. Mol. Str. 2013, 1040, 9-18
33
34
35
Laila H. Abdel-Rahman, Rafat M. El-Khatib, Lobna A. E. Nassr and Ahmed M. Abu-Dief, J. Mol. Str. 2013, 1040, 9-18
36
5 10 15 20 25 30
2 4 6 8 10 12 14 16 18 20 22
20 mg/ml 5 mg/ml
nal nali nphal nphali nas nasi nh nhi nar nari
Antibacterial evaluation
the investigated Fe(II) hydroxylnapthylidene amino acid complexes against Pseudomonus aeruginosa bacteria
37
38